ARWR
Arrowhead Pharmaceuticals, Inc.
$58.50
AlphaVal Unavailable
AlphaVal: ARWR has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.